Evidence map›Paper›PMID 40874193›Full record

ArticleOpen forum infectious diseases2025

Trajectory of

Samora Té, Edvaldo Das Neves, Ane Pellicer, Ioanna Broumou, Julia Zerebinski, Ana Santos-Reis, Taís Nóbrega de Sousa, Anna Färnert, Adalberto Santos, Maria de Jesus Santos and 2 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Samora TéScience and Community Support Service (SACC), Institute of Hygiene and Tropical Medicine, Nova University of Lisbon, Lisbon, Portugal.
Edvaldo Das NevesGlobal Health and Tropical Medicine, GHTM, Associate Laboratory in Translation and Innovation Towards Global Health, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa, UNL, Rua da Junqueira 100, 1349-008 Lisboa, Portugal.
Ane PellicerScience and Community Support Service (SACC), Institute of Hygiene and Tropical Medicine, Nova University of Lisbon, Lisbon, Portugal.ORCID https://orcid.org/0009-0001-2905-1317
Ioanna BroumouDivision of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-2376-3820
Julia ZerebinskiDivision of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-4727-4570
Ana Santos-ReisScience and Community Support Service (SACC), Institute of Hygiene and Tropical Medicine, Nova University of Lisbon, Lisbon, Portugal.
Taís Nóbrega de SousaHost Microbe Division, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-6874-9427
Anna FärnertDivision of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-7583-282X
Adalberto SantosInstituto Nacional de Saúde Pública, Ministério da Saúde, São Tomé, São Tomé and Príncipe.
Maria de Jesus SantosInstituto Nacional de Saúde Pública, Ministério da Saúde, São Tomé, São Tomé and Príncipe.
Jose Pedro GilGlobal Health and Tropical Medicine, GHTM, Associate Laboratory in Translation and Innovation Towards Global Health, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa, UNL, Rua da Junqueira 100, 1349-008 Lisboa, Portugal.ORCID https://orcid.org/0000-0002-6107-9379
Dinora LopesScience and Community Support Service (SACC), Institute of Hygiene and Tropical Medicine, Nova University of Lisbon, Lisbon, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artesunate-amodiaquine has been the first-line treatment for uncomplicated malaria in São Tomé and Príncipe since 2005, following many decades of chloroquine usage. We evaluated the recent dynamics in prevalence of the

Indexed as

ACTamodiaquinedrug resistancepfmdr1SNP

Identifiers

PMID40874193
PMCPMC12378731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.